Filing Flows

Filing Flows › Verastem (VSTM) › Next earnings date

Verastem (VSTM) earnings: missed the estimate

Verastem (VSTM) reported on Nov 5, 2026 and missed the EPS estimate: −$0.72 against −$0.44 (-63.6%). Revenue was $24.0M for Q3 2026, +114% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result−63.6% vs estimate
Beat rate80%

The last report

Verastem reported revenue of $24.0M for the third quarter 2026 (+114% Y/Y), net loss $74.7M. How it makes money → · Every quarter →

Verastem: EPS against the estimate, last 5 reportsVerastem: EPS against the estimate, last 5 reportsEstimateReported−$0.61−$0.54Nov 25−$0.50−$0.46Mar 26−$0.47−$0.43May 26−$0.45−$0.31Aug 26−$0.44−$0.72Nov 26
Latest (Nov 26): Estimate −$0.44, Reported −$0.72.
VSTM: the stock's move on each reportVSTM: the stock's move on each reportAug 6, 2026+14.8%May 7, 2026-18.6%Mar 4, 2026+8.3%Nov 4, 2025-17.6%

Verastem's latest quarter

Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Verastem beat earnings?

Verastem (VSTM) reported on Nov 5, 2026 and missed the EPS estimate: −$0.72 against −$0.44 (-63.6%).

When does VSTM report earnings?

The next date is not set yet.

Does Verastem usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.